These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5362483)

  • 21. [Phenylalanine deficiency syndrome. Case report].
    Zammarchi E
    Minerva Pediatr; 1973 Oct; 25(34):1428-32. PubMed ID: 4770448
    [No Abstract]   [Full Text] [Related]  

  • 22. Phenylketonuria: a new method for the simultaneous determination of plasma phenylalanine and tyrosine.
    Shen RS; Abell CW
    Science; 1977 Aug; 197(4304):665-7. PubMed ID: 877580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Blood amino acids in phenylketonuria. 11 cases].
    Farriaux JP; Fontaine G
    Ann Pediatr (Paris); 1969 Oct; 16(10):608-14. PubMed ID: 5357398
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic results of early detected phenylketonuric children under diet therapy].
    Ladstätter L; Schlenzka K
    Dtsch Gesundheitsw; 1971 Oct; 26(40):1891-7. PubMed ID: 5168889
    [No Abstract]   [Full Text] [Related]  

  • 25. [EEG-records for indicating the termination of dietary treatment in phenylketonuria?].
    Lässker G; Degen R; Theile H
    Padiatr Padol; 1973; 8(2):187-94. PubMed ID: 4698431
    [No Abstract]   [Full Text] [Related]  

  • 26. [Phenylketonuria. 3. Evaluation of early treatment].
    Cabalska B; Duczyńska N
    Pediatr Pol; 1969 Aug; 44(8):933-41. PubMed ID: 4310011
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical problems of the genetic heterogeneity in hyperphenylalaninemias].
    Grüttner R; Sternowsky HJ; Rybak C
    Monatsschr Kinderheilkd (1902); 1971 Nov; 119(11):600-4. PubMed ID: 5133646
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting/postprandial) in patients with phenylketonuria: effect of sample timing.
    van Spronsen FJ; van Rijn M; van Dijk T; Smit GP; Reijngoud DJ; Berger R; Heymans HS
    Pediatrics; 1993 Oct; 92(4):570-3. PubMed ID: 8414829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The action of fever on phenylalanine blood levels in phenylketonuric patients undergoing treatment].
    Bartolozzi G; Corvaglia E
    Minerva Pediatr; 1967 Aug; 19(34):1577-8. PubMed ID: 5610731
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neurologic manifestations found in children with phenylketonuria treated late or untreated].
    Czochańska J; Losiowski Z
    Neurol Neurochir Pol; 1972; 6(2):225-8. PubMed ID: 5030050
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of heterozygotes for phenylketonuria. Total body phenylalanine clearance and concentrations of phenylalanine and tyrosine in the plasms of fasting subjects compared.
    Jagenburg R; Regårdh CG; Rödjer S
    Clin Chem; 1977 Sep; 23(9):1654-60. PubMed ID: 890909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychological evaluation of treatment in phenylketonuria: intellectual, motor and social development.
    Steinhausen HC
    Neuropadiatrie; 1974 May; 5(2):146-56. PubMed ID: 4407756
    [No Abstract]   [Full Text] [Related]  

  • 33. Diurnal variations in blood phenylalanine of PKU infants under different feeding regimes.
    van Rijn M; Hoeksma M; Sauer PJ; Modderman P; Reijngoud DJ; van Spronsen FJ
    Mol Genet Metab; 2011; 104 Suppl():S68-72. PubMed ID: 21982628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of loading doses of aspartame by two phenylketonuric (PKU) children compared with two normal children.
    Koch R; Schaeffler G; Shaw NF
    J Toxicol Environ Health; 1976 Nov; 2(2):459-69. PubMed ID: 1011297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Phenylalanine concentration in the cerebrospinal fluid and blood, both entering and leaving the brain, of phenylketonuria patients].
    Bulakhova LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1542-6. PubMed ID: 4775335
    [No Abstract]   [Full Text] [Related]  

  • 36. [Phenylalanine metabolites in hyperphenylalaninemic children].
    Alvarez Domínguez L; Campistol Plana J; Ribes Rubio A; Riverola de Vecina AT
    An Esp Pediatr; 1992 May; 36(5):371-4. PubMed ID: 1616197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The early treatment of phenylketonuria.
    Kennedy JL; Wertelecki W; Gates L; Sperry BP; Cass VM
    Am J Dis Child; 1967 Jan; 113(1):16-21. PubMed ID: 6016173
    [No Abstract]   [Full Text] [Related]  

  • 38. Discriminant analysis for detection of phenylketonuric heterozygotes.
    Christian BG
    Soc Biol; 1971 Mar; 18(1):64-72. PubMed ID: 5580588
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnostic and therapeutic problems of phenylketonuria. Parallel study of 2 familial cases as a function of treatment].
    Dhondt JL; Mesmacque-Caby D; Farriaux JP; Fontaine G
    Lille Med; 1972 Nov; 17(10):1432-6. PubMed ID: 4660861
    [No Abstract]   [Full Text] [Related]  

  • 40. Fasting serum phenylalanine in untreated institutionalised patients with phenylketonuria.
    Güttler F; Wamberg E
    J Ment Defic Res; 1977 Mar; 21(1):55-62. PubMed ID: 864699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.